Nigeria is expected to receive 176,000 doses of the Johnson and Johnson COVID-19 vaccines on Wednesday.
Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, confirmed this at a news conference in Abuja on Tuesday.
He said the J&J vaccine, like the AstraZeneca, is safe and efficient against the coronavirus disease, including the deadlier Delta variant.
The J&J vaccine is a single-shot vaccine.
It is expected to boost Nigeria’s COVID-19 fight with the Delta variant sparking fears of a third wave of the pandemic.
More than 200 million cases of the pandemic have been confirmed globally, with the death toll reaching four million.
Dangote Refinery Launches IPO, Offers 4.1bn Shares At ₦525
FG Announces Closure Of First Niger Bridge For Two Weeks
Nigeria, IEA Sign Energy Partnership Agreement To Strengthen Energy Sector
Presidency Clarifies Tinubu’s US FOIA Case, Says It Is Not A Criminal Matter